Please Wait
Applying Filters...
menu
    • menu

    Looking for Capsule Extended Release Finished Formulations containing Sodium Chloride Excipient? Find Sodium Chloride Excipient based pharmaceutical excipients on PharmaCompass.

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Sodium Chloride Excipient

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1EMBEDA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ALPHARMA PHARMS

    MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

    arrow
    AAPS 2024
    Not Confirmed
    ALPHARMA PHARMS
    Ireland
    arrow
    AAPS 2024
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

    Drug : EMBEDA

    Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL

    Application Number : 22321

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF